Imexpharm Corp operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Imexpharm Corp with three other companies in this sector in VIETNAM : Mekophar Chemical Pharma JSC (2020 sales of 1.21 trillion Vietnamese Dong [US$52.42 million] ), Medipharco Pharmaceutical JSC (1.01 trillion Vietnamese Dong [US$43.85 million] ), and DOMESCO Medical Import Export Joint Stock Corp (1.45 trillion Vietnamese Dong [US$62.87 million] ).

Sales Analysis. During the year ended December of 2020, sales at Imexpharm Corp were 1.37 trillion Vietnamese Dong (US$59.30 million). This is a decrease of 2.4% versus 2019, when the company's sales were 1.40 trillion Vietnamese Dong .